572 related articles for article (PubMed ID: 1733716)
1. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
[TBL] [Abstract][Full Text] [Related]
2. Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.
Lamb JC; Levy MA; Johnson RK; Isaacs JT
Prostate; 1992; 21(1):15-34. PubMed ID: 1641369
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
Dadras SS; Cai X; Abasolo I; Wang Z
Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
[TBL] [Abstract][Full Text] [Related]
4. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
5. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
Yasuda N; Fujino K; Shiraji T; Nambu F; Kondo K
Jpn J Pharmacol; 1997 Jul; 74(3):243-52. PubMed ID: 9268084
[TBL] [Abstract][Full Text] [Related]
6. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
[TBL] [Abstract][Full Text] [Related]
7. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
Humphries JE; Isaacs JT
Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
[TBL] [Abstract][Full Text] [Related]
8. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
[TBL] [Abstract][Full Text] [Related]
9. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
11. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
Wenderoth UK; George FW; Wilson JD
Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
[TBL] [Abstract][Full Text] [Related]
12. Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells.
Martikainen P; Kyprianou N; Isaacs JT
Endocrinology; 1990 Dec; 127(6):2963-8. PubMed ID: 2249636
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of castration and 6-methylene progesterone, a 5 alpha-reductase inhibitor, on the rat ventral prostate.
Marts SA; Padilla GM; Petrow V
Biochem Cell Biol; 1987 Jul; 65(7):626-34. PubMed ID: 3435660
[TBL] [Abstract][Full Text] [Related]
14. Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment.
Avila DM; Fuqua SA; George FW; McPhaul MJ
J Endocrinol; 1998 Dec; 159(3):403-11. PubMed ID: 9834458
[TBL] [Abstract][Full Text] [Related]
15. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
Geller J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
[TBL] [Abstract][Full Text] [Related]
16. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor levels and androgen contents in the prostate lobes of intact and testosterone-treated Noble rats.
Ho SM; Damassa D; Kwan PW; Seto HS; Leav I
J Androl; 1985; 6(5):279-90. PubMed ID: 3877039
[TBL] [Abstract][Full Text] [Related]
18. Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate.
Marchetti B; Poulin R; Plante M; Labrie F
J Steroid Biochem; 1988 Oct; 31(4A):411-9. PubMed ID: 2845194
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of regrowth of prostatic glandular cells by epristeride.
Qian LH; Wang XL; Tu ZH
Acta Pharmacol Sin; 2001 Sep; 22(9):847-50. PubMed ID: 11749869
[TBL] [Abstract][Full Text] [Related]
20. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
